TipRanks

Faisal Ghiath Sukhtian Insider Profile

4 Followers
Faisal Ghiath Sukhtian, Director at Outlook Therapeutics, holds 220.97K shares in Outlook Therapeutics (Ticker: OTLK), holds ― shares in Oncobiologics Inc (Ticker: ONSIU). Most recently, Faisal Ghiath Sukhtian Bought ― shares of Outlook Therapeutics on Jul 29, 2026 for an estimated value of $99.21K.
tipranks
Faisal Ghiath Sukhtian

Faisal Ghiath Sukhtian
Outlook Therapeutics (OTLK)
Director

Ranked #16,197 out of 109,232 Corporate Insiders

Profitable Transactions

50%
3 out of 6 Profitable Transactions

Average Return

+21.10%
Average return per transaction
Time Frame
1 Year
Compare to
No Benchmark

Insider Holdings

$125K
100.00%
A breakdown of Faisal Ghiath Sukhtian's holdings

Insider Roles

Outlook Therapeutics
(OTLK)
Director
Roles that Faisal Ghiath Sukhtian holds in companies

Most Profitable Insider Trade

Stock:
Outlook Therapeutics
(OTLK)
Rating:Informative Buy
Date:Sep 17, 2020 - Sep 17, 2021
Return:+265.10%
The most profitable trade made by Faisal Ghiath Sukhtian

Faisal Ghiath Sukhtian's Trading History

Company Name
Last Transaction Date
Insider Position
Last Transaction
Last Transaction Amount
Holding Value
Outlook Therapeutics
Jul 29, 2026
Director
Informative Buy
99.21K
$124.63K
ONSIU
Oncobiologics Inc
―
―
―
―
List of latest transactions for each holding click on a transaction to see Faisal Ghiath Sukhtian's performance on stock

Faisal Ghiath Sukhtian insider profile FAQ

What is the percentage of profitable transactions made by Faisal Ghiath Sukhtian?
The percentage of profitable transactions made by Faisal Ghiath Sukhtian is 50%.
    What is the average return per transaction made by Faisal Ghiath Sukhtian?
    The average return per transaction made by Faisal Ghiath Sukhtian is 21.10%.
      What stocks does Faisal Ghiath Sukhtian hold?
      Faisal Ghiath Sukhtian holds: OTLK, ONSIU stocks.
        What was Faisal Ghiath Sukhtian’s latest transaction?
        Faisal Ghiath Sukhtian latest transaction was an Informative Buy of $99.21K.
          What was Faisal Ghiath Sukhtian's most profitable transaction?
          Faisal Ghiath Sukhtian’s most profitable transaction was an Informative Buy of OTLK stock on September 17, 2020. The return on the trade was 265.10%.
            What is Faisal Ghiath Sukhtian's role in Outlook Therapeutics?
            Faisal Ghiath Sukhtian's role in Outlook Therapeutics is Director.
              How can I follow the stock ratings of top corporate insiders?
              Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.